An Analysis of Trends and Growth Factor Receptor Expression of GI Carcinoid Tumors
Authors:
- 7 July 2009
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 13 (10) , 1773-1780
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Development and Characterization of a Novel In vivo Model of Carcinoid SyndromeClinical Cancer Research, 2009
- Carcinoid TumorsThe Oncologist, 2008
- Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine TumorsJNCI: Journal of the National Cancer Institute, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- ErbB receptors: from oncogenes to targeted cancer therapiesJournal of Clinical Investigation, 2007
- Targeted Molecular Therapy of the PI3K PathwayAnnals of Surgery, 2006
- Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281Journal of Clinical Oncology, 2005
- A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 2005
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomasThe Journal of Pathology, 2002